0.00Open0.95Pre Close0 Volume14 Open Interest1.00Strike Price0.00Turnover0.00%IV54.55%PremiumDec 20, 2024Expiry Date0.89Intrinsic Value100Multiplier28DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.15Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eyenovia Stock Discussion
Eyenovia Provides Update on Restructuring Efforts
Eyenovia (NASDAQ: EYEN) has secured an agreement with Avenue Capital Management to defer principal and interest payments on its outstanding debt until February 2025. The ophthalmic technology company is implementing additional restructuring measures, including a reduction in personnel-related costs by over 70%. The company is exploring various strategic alternatives, which may include a business combination, reverse merger...
Can a reverse stick split occur for this stock or cannot?
Half the workforce cut. Is it on the verge of bankruptcy?
Eyenovia Inc - Is in Discussions With Avenue Capital Management L.p. Regarding a Potential Restructuring
No comment yet